These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15914282)

  • 21. Mutations in Tp53 gene sequences from lung tumors in rats that inhaled plutonium dioxide.
    Yamada Y; Oghiso Y
    Radiat Res; 1999 Dec; 152(6 Suppl):S107-9. PubMed ID: 10564948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low level of microsatellite instability in paediatric malignant astrocytomas.
    Vladimirova V; Denkhaus D; Soerensen N; Wagner S; Wolff JE; Pietsch T
    Neuropathol Appl Neurobiol; 2008 Oct; 34(5):547-54. PubMed ID: 18053027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A highly sensitive detection method for somatic mutations in p53 gene.
    Sato T; Sato A; Ishihara H; Konishi K
    Rinsho Byori; 2003 Feb; 51(2):98-106. PubMed ID: 12690626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of mutated TP53 on cDNA (but not on DNA template) in pleomorphic xanthoastrocytoma with positive TP53 immunohistochemistry.
    Zakrzewska M; Szybka M; Biernat W; Papierz T; Rieske P; Liberski PP; Zakrzewski K
    Cancer Genet Cytogenet; 2009 Sep; 193(2):93-7. PubMed ID: 19665069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
    Liu Y; Bodmer WF
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry.
    Koga H; Zhang S; Kumanishi T; Washiyama K; Ichikawa T; Tanaka R; Mukawa J
    Acta Neuropathol; 1994; 87(3):225-32. PubMed ID: 8009954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents.
    Loyant V; Jaffré A; Breton J; Baldi I; Vital A; Chapon F; Dutoit S; Lecluse Y; Loiseau H; Lebailly P; Gauduchon P
    Mutagenesis; 2005 Sep; 20(5):365-73. PubMed ID: 16105905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors.
    Favis R; Huang J; Gerry NP; Culliford A; Paty P; Soussi T; Barany F
    Hum Mutat; 2004 Jul; 24(1):63-75. PubMed ID: 15221790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
    Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J
    Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splice mutations in the p53 gene: case report and review of the literature.
    Holmila R; Fouquet C; Cadranel J; Zalcman G; Soussi T
    Hum Mutat; 2003 Jan; 21(1):101-2. PubMed ID: 12497643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas.
    Gaiser T; Becker MR; Meyer J; Habel A; Siegelin MD
    Neurochem Int; 2009 Jun; 54(7):458-63. PubMed ID: 19428789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [p53 gene mutations in brain tumors].
    Koga H; Kumanishi T
    No To Shinkei; 1995 Sep; 47(9):845-55. PubMed ID: 7546933
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations.
    Arjona D; Bello MJ; Alonso ME; Aminoso C; Isla A; De Campos JM; Sarasa JL; Gutierrez M; Villalobo A; Rey JA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):384-94. PubMed ID: 16008822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma.
    Saito K; Yokogami K; Maekawa K; Sato Y; Yamashita S; Matsumoto F; Mizuguchi A; Takeshima H
    Hum Cell; 2021 Mar; 34(2):644-653. PubMed ID: 33454902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
    Gupta M; Djalilvand A; Brat DJ
    Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
    Gorlov IP; Gorlova OY; Frazier ML; Amos CI
    Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan.
    Amikura T; Sekine M; Hirai Y; Fujimoto S; Hatae M; Kobayashi I; Fujii T; Nagata I; Ushijima K; Obata K; Suzuki M; Yoshinaga M; Umesaki N; Satoh S; Enomoto T; Motoyama S; Nishino K; Haino K; Tanaka K;
    Gynecol Oncol; 2006 Feb; 100(2):365-71. PubMed ID: 16337994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors.
    Hayes VM; Dirven CM; Dam A; Verlind E; Molenaar WM; Mooij JJ; Hofstra RM; Buys CH
    Brain Pathol; 1999 Jul; 9(3):463-7. PubMed ID: 10416986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PIK3CA mutations in glioblastoma multiforme.
    Hartmann C; Bartels G; Gehlhaar C; Holtkamp N; von Deimling A
    Acta Neuropathol; 2005 Jun; 109(6):639-42. PubMed ID: 15924253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
    Olivier M; Langerød A; Carrieri P; Bergh J; Klaar S; Eyfjord J; Theillet C; Rodriguez C; Lidereau R; Bièche I; Varley J; Bignon Y; Uhrhammer N; Winqvist R; Jukkola-Vuorinen A; Niederacher D; Kato S; Ishioka C; Hainaut P; Børresen-Dale AL
    Clin Cancer Res; 2006 Feb; 12(4):1157-67. PubMed ID: 16489069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.